NASDAQ: HCSG
HEALTHCARE SERVICES GROUP INCCIK 0000731012 · SIC 8050 · Nursing & Personal Care Facilities
Mid
Revenue $1.8B
Assets $821M
as of Sep 6, 2026
Every 8-K is open in full. Other 10-Ks and 10-Qs show a 3-bullet preview. A free account reads 3 more full reports a month. Generating a report requires a verified account.
Sign up freeWant to see a complete report first? Today's free report (DBI 10-Q) is open in full — no account needed.
10-Q
Filed Jul 24, 2026
· Period ending Jun 30, 2026
Summary not yet generated.
8-K
Filed Jul 22, 2026
· Period ending Jul 22, 2026
Summary not yet generated.
Partner
Trade HCSG commission-free
Open an account, get a free stock.
Investing involves risk. Free stock terms apply.
8-K
Filed May 27, 2026
· Period ending May 26, 2026
Summary not yet generated.
10-Q
Filed Apr 24, 2026
· Period ending Mar 31, 2026
Summary not yet generated.
8-K
Filed Apr 22, 2026
· Period ending Apr 22, 2026
Summary not yet generated.
10-K
Filed Feb 13, 2026
· Period ending Dec 31, 2025
Summary not yet generated.
10-K
Filed Feb 14, 2025
· Period ending Dec 31, 2024
Summary not yet generated.
Latest financial statements
From 10-Q filed Jul 24, 2026 (period ending Jun 30, 2026). As printed on the EDGAR/iXBRL face — not generated by the model.
Consolidated Statements of Comprehensive Income (Unaudited)
(in thousands, except per share amounts)
| Description | Three months ended June 30, 2026 | Three months ended June 30, 2025 | Six months ended June 30, 2026 | Six months ended June 30, 2025 |
|---|---|---|---|---|
| Revenues | 470,808 | 458,491 | 933,574 | 906,153 |
| Operating costs and expenses: | ||||
| Costs of services provided | 396,015 | 455,533 | 782,946 | 835,224 |
| Selling, general and administrative | 52,585 | 49,163 | 94,582 | 94,129 |
| Other income (expense): | ||||
| Investment and other income, net | 9,414 | 4,735 | 10,482 | 6,019 |
| Interest expense | (619) | (418) | (984) | (813) |
| Income (loss) before taxes | 31,003 | (41,888) | 65,544 | (17,994) |
| Income tax provision (benefit) | 8,307 | (9,522) | 16,788 | (2,856) |
| Net income (loss) | 22,696 | (32,366) | 48,756 | (15,138) |
| Per share data: | ||||
| Basic earnings (loss) per common share | 0.33 | (0.44) | 0.70 | (0.21) |
| Diluted earnings (loss) per common share | 0.32 | (0.44) | 0.69 | (0.21) |
| Weighted average number of common shares outstanding: | ||||
| Basic | 68,758 | 73,161 | 69,311 | 73,414 |
| Diluted | 69,905 | 73,161 | 70,479 | 73,414 |
| Comprehensive income (loss): | ||||
| Net income (loss) | 22,696 | (32,366) | 48,756 | (15,138) |
| Other comprehensive income (loss) | ||||
| Unrealized (loss) gain on available-for-sale marketable securities, net of taxes | (103) | 372 | (490) | 875 |
| Total comprehensive income (loss) | 22,593 | (31,994) | 48,266 | (14,263) |
Consolidated Balance Sheets (Unaudited)
(in thousands, except per share amounts)
| Description | June 30, 2026 (unaudited) | December 31, 2025 |
|---|---|---|
| Current assets: | ||
| Cash and cash equivalents | 123,406 | 125,189 |
| Restricted cash equivalents | 54 | 5,577 |
| Marketable securities, at fair value | 41,316 | 42,774 |
| Restricted marketable securities, at fair value | 36,089 | 30,352 |
| Accounts receivable, net (less allowances: $118,291 and $119,305) | 292,794 | 281,303 |
| Notes receivable short–term portion, net (less allowances: $28,371 and $25,931) | 26,676 | 31,243 |
| Inventories and supplies | 15,837 | 16,797 |
| Taxes receivable | 4,664 | 22,246 |
| Prepaid expenses and other current assets | 27,689 | 20,934 |
| Total current assets | 568,525 | 576,415 |
| Property and equipment, net | 29,922 | 27,586 |
| Goodwill | 85,804 | 79,797 |
| Other intangible assets (less accumulated amortization of $44,402 and $42,931) | 13,112 | 6,964 |
| Notes receivable long–term portion, net (less allowances: $3,547 and $1,776) | 34,862 | 25,209 |
| Deferred compensation funding, at fair value | 59,141 | 55,909 |
| Deferred tax assets | 19,923 | 18,472 |
| Other long-term assets | 9,568 | 3,901 |
| Total assets | 820,857 | 794,253 |
| LIABILITIES AND STOCKHOLDERS’ EQUITY: | ||
| Current liabilities: | ||
| Accounts payable | 86,097 | 77,382 |
| Accrued payroll and related taxes | 44,020 | 31,400 |
| Other accrued expenses and current liabilities | 35,877 | 37,222 |
| Accrued insurance claims | 22,124 | 24,371 |
| Total current liabilities | 188,118 | 170,375 |
| Accrued insurance claims long-term | 42,619 | 46,142 |
| Deferred compensation liability long-term | 59,141 | 56,276 |
| Lease liability long-term | 11,328 | 9,659 |
| Other long-term liabilities | 809 | 1,591 |
| Commitments and contingencies (Note 17) | ||
| STOCKHOLDERS’ EQUITY: | ||
| Common stock, $0.01 par value; 200,000 shares authorized; 77,298 and 76,821 shares issued, and 67,983 and 69,596 shares outstanding | 773 | 768 |
| Additional paid-in capital | 331,398 | 327,956 |
| Retained earnings | 332,427 | 283,668 |
| Accumulated other comprehensive loss, net of taxes | (938) | (448) |
| Common stock in treasury, at cost, 9,315 and 7,225 shares | (144,818) | (101,734) |
| Total stockholders’ equity | 518,842 | 510,210 |
| Total liabilities and stockholders’ equity | 820,857 | 794,253 |
Consolidated Statements of Cash Flows (Unaudited)
(in thousands)
| Description | Six months ended June 30, 2026 | Six months ended June 30, 2025 |
|---|---|---|
| Cash flows from operating activities: | ||
| Net income (loss) | 48,756 | (15,138) |
| Adjustments to reconcile net income (loss) to net cash from operating activities: | ||
| Depreciation and amortization | 7,326 | 8,879 |
| Bad debt provision | 8,052 | 73,381 |
| Deferred income taxes | (1,322) | (15,180) |
| Share-based compensation expense | 5,585 | 6,279 |
| Amortization of premium on marketable securities | 67 | 235 |
| Unrealized gain on deferred compensation fund investments | (5,424) | (3,195) |
| Changes in other long-term assets and liabilities | (16) | (2,763) |
| Net loss on disposals of property and equipment | 181 | 161 |
| Changes in operating assets and liabilities: | ||
| Accounts and notes receivable | (24,443) | (15,759) |
| Inventories and supplies | 960 | (607) |
| Prepaid expenses and other assets | (7,696) | 843 |
| Deferred compensation funding | 2,140 | 715 |
| Accounts payable and other accrued expenses | 1,968 | (10,887) |
| Accrued payroll and related taxes | 14,295 | 15,665 |
| Deferred ERC credits | — | 20,016 |
| Income taxes receivable (payable) | 17,582 | (7,003) |
| Accrued insurance claims | (5,770) | (1,605) |
| Deferred compensation liability | 3,359 | 2,251 |
| Net cash from operating activities | 65,600 | 56,288 |
| Cash flows from investing activities: | ||
| Disposals of property and equipment | 143 | 76 |
| Additions to property and equipment | (3,028) | (3,102) |
| Cash paid for acquisition, net of cash acquired | (12,794) | (7,287) |
| Cash paid for investments | (4,625) | (2,125) |
| Purchases of marketable securities | (16,967) | (4,611) |
| Sales of marketable securities | 11,967 | 229 |
| Net cash from investing activities | (25,304) | (16,820) |
| Cash flows from financing activities: | ||
| Purchases of treasury stock | (44,892) | (14,711) |
| Payments of statutory withholding on net issuance of restricted stock units | (4,162) | (1,744) |
| Proceeds from the exercise of stock options | 1,452 | — |
| Net cash from financing activities | (47,602) | (16,455) |
| Net (decrease) increase in cash, cash equivalents and restricted cash equivalents | (7,306) | 23,013 |
| Cash, cash equivalents and restricted cash equivalents at beginning of the period | 130,766 | 60,131 |
| Cash, cash equivalents and restricted cash equivalents at end of the period | 123,460 | 83,144 |
Amounts as printed on the EDGAR/iXBRL face — (in thousands, except per share amounts); (in thousands). Labels, columns, and figures are the filing face, not a GAAP stencil. Interactive statements & notes on EDGAR ↗